FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893547232> ?p ?o ?g. }

• W2893547232 endingPage "8" @default.
• W2893547232 startingPage "1" @default.
• W2893547232 abstract "Recent European Society of Cardiology and American Heart Association/American College of Cardiology Guidelines did not recommend biomarker-guided therapy in the management of heart failure (HF) patients. Combination of echo- and B-type natriuretic peptide (BNP) may be an alternative approach in guiding ambulatory HF management. Our aim was to determine whether a therapy guided by echo markers of left ventricular filling pressure (LVFP), lung ultrasound (LUS) assessment of B-lines, and BNP improves outcomes of HF patients. Consecutive outpatients with LV ejection fraction (EF) ≤ 50% have been prospectively enrolled. In Group I (<mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M1><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>224</mml:mn></mml:mrow></mml:math>), follow-up was guided by echo and BNP with the goal of achieving E-wave deceleration time (EDT) ≥ 150 ms, tissue Doppler index E / e ′ < 13, B-line numbers < 15, and BNP ≤ 125 pg/ml or decrease >30%; in Group II (<mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M2><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>293</mml:mn></mml:mrow></mml:math>), follow-up was clinically guided, while the remaining 277 patients (Group III) did not receive any dedicated follow-up. At 60 months, survival was 88% in Group I compared to 75% in Group II and 54% in Group III ( χ 2 53.5; <mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M3><mml:mrow><mml:mi>p</mml:mi><mml:mo><</mml:mo><mml:mn>0.0001</mml:mn></mml:mrow></mml:math>). Survival curves exhibited statistically significant differences using Mantel–Cox analysis. The number needed to treat to spare one death was 7.9 (Group I versus Group II) and 3.8 (Group I versus Group III). At multivariate Cox regression analyses, major predictors of all-cause mortality were follow-up E / e ′ (HR: 1.05; <mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M4><mml:mrow><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.0038</mml:mn></mml:mrow></mml:math>) and BNP >125 pg/ml or decrease ≤30% (HR: 4.90; <mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M5><mml:mrow><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.0054</mml:mn></mml:mrow></mml:math>), while BNP > 125 pg/ml or decrease ≤30% and B-line numbers ≥15 were associated with the combined end point of death and HF hospitalization. Evidence-based HF treatment guided by serum biomarkers and ultrasound with the goal of reducing elevated BNP and LVFP, and resolving pulmonary congestion was associated with better clinical outcomes and can be valuable in guiding ambulatory HF management." @default.
• W2893547232 created "2018-10-05" @default.
• W2893547232 creator A5002163579 @default.
• W2893547232 creator A5005417269 @default.
• W2893547232 creator A5007252462 @default.
• W2893547232 creator A5010103796 @default.
• W2893547232 creator A5020420865 @default.
• W2893547232 creator A5025110444 @default.
• W2893547232 creator A5028647622 @default.
• W2893547232 creator A5037536262 @default.
• W2893547232 creator A5041695168 @default.
• W2893547232 creator A5056385875 @default.
• W2893547232 creator A5082387806 @default.
• W2893547232 creator A5091607246 @default.
• W2893547232 date "2018-09-30" @default.
• W2893547232 modified "2023-10-03" @default.
• W2893547232 title "Echo- and B-Type Natriuretic Peptide-Guided Follow-Up versus Symptom-Guided Follow-Up: Comparison of the Outcome in Ambulatory Heart Failure Patients" @default.
• W2893547232 cites W1524863043 @default.
• W2893547232 cites W1966329493 @default.
• W2893547232 cites W1966689746 @default.
• W2893547232 cites W2037733417 @default.
• W2893547232 cites W2047775345 @default.
• W2893547232 cites W2052953200 @default.
• W2893547232 cites W2095188019 @default.
• W2893547232 cites W2099769151 @default.
• W2893547232 cites W2103207704 @default.
• W2893547232 cites W2106742300 @default.
• W2893547232 cites W2113698123 @default.
• W2893547232 cites W2119340816 @default.
• W2893547232 cites W2124624517 @default.
• W2893547232 cites W2126336638 @default.
• W2893547232 cites W2127386115 @default.
• W2893547232 cites W2137147239 @default.
• W2893547232 cites W2149537759 @default.
• W2893547232 cites W2152264817 @default.
• W2893547232 cites W2288740513 @default.
• W2893547232 cites W2427094903 @default.
• W2893547232 cites W2465883722 @default.
• W2893547232 cites W2520557500 @default.
• W2893547232 cites W2558238271 @default.
• W2893547232 cites W2604086082 @default.
• W2893547232 cites W2607335081 @default.
• W2893547232 cites W2607538050 @default.
• W2893547232 cites W2620258857 @default.
• W2893547232 cites W2745438221 @default.
• W2893547232 cites W2761443392 @default.
• W2893547232 cites W2766271374 @default.
• W2893547232 cites W2791384486 @default.
• W2893547232 cites W38725997 @default.
• W2893547232 cites W82015992 @default.
• W2893547232 doi "https://doi.org/10.1155/2018/3139861" @default.
• W2893547232 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6186350" @default.
• W2893547232 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30363950" @default.
• W2893547232 hasPublicationYear "2018" @default.
• W2893547232 type Work @default.
• W2893547232 sameAs 2893547232 @default.
• W2893547232 citedByCount "11" @default.
• W2893547232 countsByYear W28935472322019 @default.
• W2893547232 countsByYear W28935472322020 @default.
• W2893547232 countsByYear W28935472322021 @default.
• W2893547232 countsByYear W28935472322022 @default.
• W2893547232 countsByYear W28935472322023 @default.
• W2893547232 crossrefType "journal-article" @default.
• W2893547232 hasAuthorship W2893547232A5002163579 @default.
• W2893547232 hasAuthorship W2893547232A5005417269 @default.
• W2893547232 hasAuthorship W2893547232A5007252462 @default.
• W2893547232 hasAuthorship W2893547232A5010103796 @default.
• W2893547232 hasAuthorship W2893547232A5020420865 @default.
• W2893547232 hasAuthorship W2893547232A5025110444 @default.
• W2893547232 hasAuthorship W2893547232A5028647622 @default.
• W2893547232 hasAuthorship W2893547232A5037536262 @default.
• W2893547232 hasAuthorship W2893547232A5041695168 @default.
• W2893547232 hasAuthorship W2893547232A5056385875 @default.
• W2893547232 hasAuthorship W2893547232A5082387806 @default.
• W2893547232 hasAuthorship W2893547232A5091607246 @default.
• W2893547232 hasBestOaLocation W28935472321 @default.
• W2893547232 hasConcept C11413529 @default.
• W2893547232 hasConcept C119857082 @default.
• W2893547232 hasConcept C126322002 @default.
• W2893547232 hasConcept C164705383 @default.
• W2893547232 hasConcept C2775915353 @default.
• W2893547232 hasConcept C2778198053 @default.
• W2893547232 hasConcept C2989005 @default.
• W2893547232 hasConcept C33923547 @default.
• W2893547232 hasConcept C35785553 @default.
• W2893547232 hasConcept C41008148 @default.
• W2893547232 hasConcept C71924100 @default.
• W2893547232 hasConcept C78085059 @default.
• W2893547232 hasConceptScore W2893547232C11413529 @default.
• W2893547232 hasConceptScore W2893547232C119857082 @default.
• W2893547232 hasConceptScore W2893547232C126322002 @default.
• W2893547232 hasConceptScore W2893547232C164705383 @default.
• W2893547232 hasConceptScore W2893547232C2775915353 @default.
• W2893547232 hasConceptScore W2893547232C2778198053 @default.
• W2893547232 hasConceptScore W2893547232C2989005 @default.
• W2893547232 hasConceptScore W2893547232C33923547 @default.
• W2893547232 hasConceptScore W2893547232C35785553 @default.
• W2893547232 hasConceptScore W2893547232C41008148 @default.

• next